FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026195939> ?p ?o ?g. }

• W2026195939 endingPage "1052" @default.
• W2026195939 startingPage "1046" @default.
• W2026195939 abstract "Background. This study investigated the effect of the antineoplastic agent gemcitabine (dFdC) in combination with cyclosporine (CsA) or with FK506 on acute heart allograft rejection in a rat model. Methods. Transplantations were performed in the fully allogeneic Lewis-to-Brown Norway strain combination. dFdC, CsA, and FK506 single-drug therapy and combinations of dFdC with CsA and FK506 were administered at various dosages starting on day 1 to prevent and on day 4 to treat acute rejection until day 20. Animals who did not reject their graft were intraperitoneally injected with 108 splenic donor-type lymphocytes. In addition, Lewis and third-party skin grafts were transplanted to these animals. Results. Mean graft survival times under CsA, FK506, and dFdC monotherapy were 18.3/63.7 days (1 mg/5 mg per kg), 41.7 days, and 24.7/38.7 days (100 μg/150 μg per kg), respectively. CsA and FK506 in combination with dFdC prolonged graft survival to more than 100 days (CsA) and more than 95.2 days (FK506). Graft survival after treatment of an ongoing rejection was 21.5/38.3 days for CsA (1 mg/5 mg per kg) and 17.7/59.2 days for dFdC (100 μg/150 μg per kg). The combination of CsA+dFdC prompted indefinite survival of five of six hearts. Lymphocyte inoculation did not induce graft rejection. Notably, none of the Lewis, but all third-party, skin grafts were rejected immediately. Histomorphologic analysis of grafted hearts, however, demonstrated typical features of chronic rejection. Conclusions. The combination of CsA and FK506 with low-dose dFdC exerts a synergistic effect in the prevention and treatment of acute allograft rejection in this model. Although chronic rejection could not be prevented, strain-specific tolerance was achieved. Therefore, combining standard immunosuppressants with dFdC is a novel, promising strategy for prevention and treatment of acute allograft rejection." @default.
• W2026195939 created "2016-06-24" @default.
• W2026195939 creator A5002749143 @default.
• W2026195939 creator A5012338143 @default.
• W2026195939 creator A5017825431 @default.
• W2026195939 creator A5030839519 @default.
• W2026195939 creator A5035603410 @default.
• W2026195939 creator A5046688891 @default.
• W2026195939 creator A5048801119 @default.
• W2026195939 creator A5055808022 @default.
• W2026195939 creator A5067267656 @default.
• W2026195939 creator A5079161240 @default.
• W2026195939 creator A5087598341 @default.
• W2026195939 date "2003-10-15" @default.
• W2026195939 modified "2023-10-18" @default.
• W2026195939 title "Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat" @default.
• W2026195939 cites W1542563774 @default.
• W2026195939 cites W1840050571 @default.
• W2026195939 cites W1862964936 @default.
• W2026195939 cites W1973318133 @default.
• W2026195939 cites W1980818329 @default.
• W2026195939 cites W1985253103 @default.
• W2026195939 cites W1993051112 @default.
• W2026195939 cites W1995067613 @default.
• W2026195939 cites W1995764584 @default.
• W2026195939 cites W2012963926 @default.
• W2026195939 cites W2029515374 @default.
• W2026195939 cites W2044457148 @default.
• W2026195939 cites W2058654484 @default.
• W2026195939 cites W2062189901 @default.
• W2026195939 cites W2078198415 @default.
• W2026195939 cites W2083543917 @default.
• W2026195939 cites W2090312880 @default.
• W2026195939 cites W2098100304 @default.
• W2026195939 cites W2102942510 @default.
• W2026195939 cites W2154737435 @default.
• W2026195939 doi "https://doi.org/10.1097/01.tp.0000090544.17227.57" @default.
• W2026195939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14557751" @default.
• W2026195939 hasPublicationYear "2003" @default.
• W2026195939 type Work @default.
• W2026195939 sameAs 2026195939 @default.
• W2026195939 citedByCount "5" @default.
• W2026195939 countsByYear W20261959392015 @default.
• W2026195939 countsByYear W20261959392018 @default.
• W2026195939 crossrefType "journal-article" @default.
• W2026195939 hasAuthorship W2026195939A5002749143 @default.
• W2026195939 hasAuthorship W2026195939A5012338143 @default.
• W2026195939 hasAuthorship W2026195939A5017825431 @default.
• W2026195939 hasAuthorship W2026195939A5030839519 @default.
• W2026195939 hasAuthorship W2026195939A5035603410 @default.
• W2026195939 hasAuthorship W2026195939A5046688891 @default.
• W2026195939 hasAuthorship W2026195939A5048801119 @default.
• W2026195939 hasAuthorship W2026195939A5055808022 @default.
• W2026195939 hasAuthorship W2026195939A5067267656 @default.
• W2026195939 hasAuthorship W2026195939A5079161240 @default.
• W2026195939 hasAuthorship W2026195939A5087598341 @default.
• W2026195939 hasBestOaLocation W20261959391 @default.
• W2026195939 hasConcept C126322002 @default.
• W2026195939 hasConcept C126894567 @default.
• W2026195939 hasConcept C203014093 @default.
• W2026195939 hasConcept C2776090121 @default.
• W2026195939 hasConcept C2776694085 @default.
• W2026195939 hasConcept C2778740727 @default.
• W2026195939 hasConcept C2778849806 @default.
• W2026195939 hasConcept C2779528694 @default.
• W2026195939 hasConcept C2780252810 @default.
• W2026195939 hasConcept C2780258809 @default.
• W2026195939 hasConcept C2909675724 @default.
• W2026195939 hasConcept C2911091166 @default.
• W2026195939 hasConcept C71924100 @default.
• W2026195939 hasConcept C8891405 @default.
• W2026195939 hasConcept C98274493 @default.
• W2026195939 hasConceptScore W2026195939C126322002 @default.
• W2026195939 hasConceptScore W2026195939C126894567 @default.
• W2026195939 hasConceptScore W2026195939C203014093 @default.
• W2026195939 hasConceptScore W2026195939C2776090121 @default.
• W2026195939 hasConceptScore W2026195939C2776694085 @default.
• W2026195939 hasConceptScore W2026195939C2778740727 @default.
• W2026195939 hasConceptScore W2026195939C2778849806 @default.
• W2026195939 hasConceptScore W2026195939C2779528694 @default.
• W2026195939 hasConceptScore W2026195939C2780252810 @default.
• W2026195939 hasConceptScore W2026195939C2780258809 @default.
• W2026195939 hasConceptScore W2026195939C2909675724 @default.
• W2026195939 hasConceptScore W2026195939C2911091166 @default.
• W2026195939 hasConceptScore W2026195939C71924100 @default.
• W2026195939 hasConceptScore W2026195939C8891405 @default.
• W2026195939 hasConceptScore W2026195939C98274493 @default.
• W2026195939 hasIssue "7" @default.
• W2026195939 hasLocation W20261959391 @default.
• W2026195939 hasLocation W20261959392 @default.
• W2026195939 hasLocation W20261959393 @default.
• W2026195939 hasOpenAccess W2026195939 @default.
• W2026195939 hasPrimaryLocation W20261959391 @default.
• W2026195939 hasRelatedWork W1523321742 @default.
• W2026195939 hasRelatedWork W2010352178 @default.
• W2026195939 hasRelatedWork W2118940674 @default.
• W2026195939 hasRelatedWork W2136579767 @default.
• W2026195939 hasRelatedWork W2181247111 @default.

• next